Enzymatic inactivation of major circulating forms of atrial and brain natriuretic peptides
- 1 April 1999
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 370 (3) , 307-312
- https://doi.org/10.1016/s0014-2999(99)00115-6
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 21 references indexed in Scilit:
- Functional evidence for an apical ANP receptor in LLC-PK1 kidney epithelial cellsEuropean Journal of Pharmacology: Molecular Pharmacology, 1994
- Nonlinear mixed effect modeling of the pharmacodynamics of natriuretic peptides in ratsJournal of Pharmacokinetics and Biopharmaceutics, 1993
- Characterization of natriuretic peptide receptors in cultured cells.Hypertension, 1992
- Selective Activation of the B Natriuretic Peptide Receptor by C-Type Natriuretic Peptide (CNP)Science, 1991
- Degradation of brain natriuretic peptide by neutral endopeptidase: Species specific sites of proteolysis determined by mass spectrometryBiochemical and Biophysical Research Communications, 1991
- Increased Human Brain Natriuretic Peptide in Congestive Heart FailureNew England Journal of Medicine, 1990
- A membrane form of guanylate cyclase is an atrial natriuretic peptide receptorNature, 1989
- Urodilatin (CDD/ANP‐95‐126) is not biologically inactivated by a peptidase from dog kidney cortex membranes in contrast to atrial natriuretic peptide/cardiodilatin (α‐hANP/CDD‐99‐126)FEBS Letters, 1988
- Role of endopeptidase‐24.11 in the inactivation of atrial natriuretic peptideFEBS Letters, 1988
- Specific receptors for atrial natriuretic polypeptide on basolateral membranes isolated from rat renal cortexBiochemical and Biophysical Research Communications, 1985